Why AI Is Forcing Big Pharma to Turn to China
Artificial intelligence has not solved drug discovery. It has exposed where pharmaceutical development really fails. As decision-making replaces invention as the bottleneck, Western drugmakers are quietly reorganising pipelines and partnerships pulling China into the system not by admiration, but by necessity.